Health-Holland

Biotechnology companies Biotechnology is a prominent feature of the Netherlands’ Life Sciences landscape. The country is home to numerous innovative biotechnology companies - from start-ups, to SMEs to large organisations – that operate in the areas of health, nutrition, or the bio-based economy. Playing a key role in establishing this Source: The Dutch Life Sciences Trend Analysis 2018 Biotechnology companies by ownership status Private / independent 85.7% Subsidiary 12.1% Publicly listed on stock exchange 2.2% Source: The Dutch Life Sciences Trend Analysis 2018 Key activities of biotechnology companies AgroBio 6.9% Bioinformatics and Bioelectronics 4.7% Contact Research and Manufacturing 12.3% Cosmetics 1.4% Diagnostics and Analytical Services 16.7% Drug Delivery 2.7% Environment 1.2% Food and Nutraceuticals 5.9% Genomics and Proteomics 7.3% Industrial Biotechnology 1% Other Services and Suppliers 23.3% Therapeutics 13% Veterinary 3.3% thriving segment are Dutch scientists and entrepreneurs such as Herbert Heyneker, Hubert Schoemaker and Henri Termeer. Over the past few decades, biotech companies in the Netherlands such as Galapagos, Genmab and Kiadis, have made significant contributions to the development of new medicines, diagnostics, and industry products that have contributed significantly to global society, sustainability, and health. The majority of biotech companies located in the Netherlands (85.7%) are private or independent organisations and and are primarily engaged in therapeutics, diagnostics and analytical services, and associated services and supplies. 21